Overexpression and tumor-promoting activities of PZR have been observed in many types of cancers including advanced gallbladder carcinoma, ovarian cancer, and hepatocellular carcinoma [12–14]. This evidence concerns the gene MPZL1 and hepatocellular carcinoma.